ADSK Forensic analysis
Price Targets (12m)
Detailed research
PART 1: TRADING EXECUTION
Trading Setup & Entry Strategy
- >Entry Zone: $238.00 - $241.00. Focus on the convergence of the 10-day SMA ($239.87) and 50-day SMA ($240.48).
- >Scaling Strategy: Enter 40% at $240.50, add 30% at $238.50 if the consolidation holds, final 30% on a confirmed break above $245.00.
- >Stop Loss: $227.50 (HARD stop, just below the lower Bollinger Band support).
- >Take Profit: $262.00 (initial) and $275.00 (approaching the 200-day SMA).
- >Risk/Reward: ~1:2.3 based on initial entry and primary TP.
- >Max Hold: 2 weeks.
PART 2: DETAILED RESEARCH
Financial Health & Valuation
Autodesk exhibits strong recurring revenue dynamics (97% of total revenue). Revenue grew 18% YoY to $7.21B. While the internal audit (concluded August 2025) caused volatility, the business remains fundamentally sound with high sticky-revenue. The 14% growth in deferred revenue and 20% increase in RPO suggests healthy forward demand.
Technical Reconciliation
ADSK is in a BULLISH_CROSSING phase with the RSI at a neutral 53.86. The stock has reclaimed its 5-day and 50-day SMAs but remains significantly below the 200-day SMA ($276.89). The current setup is a classic recovery play: the stock is building a base above the 50-day SMA, indicating potential for a trend reversal toward the 200-day mean.
Forensic Accounting & Red Flags
- [CRIT]SBC/Dilution: Share-based compensation remains high (~$788M). Investors must monitor the impact of continued stock repurchases to offset this dilution.
- [WARN]Audit Aftermath: The legal hurdles (class actions/derivative suits) have largely cleared (dismissed with prejudice in Jan 2026), removing the primary overhang from the stock.
Investment Recommendation
RATING: BUY (Speculative Swing). The fundamental value is catching up to the technical recovery. We are playing a mean-reversion toward the 200-day SMA while respecting the volatility in the software sector.
"Autodesk's transition to a direct transaction model and focus on AI-driven workflows are starting to show in the RPO growth; the stock is shedding its 'legal-hangover' discount and is positioned for a technical test of the 200-day moving average."